April 29, 2020
Event Recap: Responding to COVID-19 A Ground-Zero Perspective from Washington’s Life Science Community
Life Science Washington and the University of Washington through the WE-REACH Biomedical Entrepreneurship Center teamed up to share stories and perspectives from scientists, researchers, and policymakers about the COVID-19 response. If you missed the webinar held April 23 with experts in Seattle talking about where we are with COVID-19 you can watch the video here. Recaps and…
April 24, 2020
UW Entrepreneurial Law Clinic Resources for COVID-19
The University of Washington Entrepreneurial Law Clinic (a collaborator with WE-REACH) has put together a set of resources to help businesses grappling with COVID-19. In particular, they have several links for R&D funding and grants for Life Sciences businesses. For the full list of Entrepreneurial Law Clinic resources, follow the link.
March 26, 2020
WE-REACH Executive Director Talks Covid-19 with USA Today, Salon, and Geekwire
Dr. Rodney Ho, the Principal Investigator (PI) and Director of the Center for WE-REACH talked with USA Today, Salon, and Geekwire to discuss remdesivir, lopinavir, and hydrocholoroquinine as potential treatments for Covid-19. As part of the center’s focus on providing scientists a bridge to medical impact, WE-REACH has prepared a list of funding opportunities with the NIH. For…
March 20, 2020
Funding for Coronavirus 2019 Treatments, Diagnostics, and Related Solutions
Congress and US federal agencies have responded to the coronavirus threat with funding aimed at fast-tracking promising technologies and products that can help address the needs. Examples of recently funded projects include support of the first high-throughput COVID-19 diagnostic test from Hologic as well as tests from several other companies. Medical Countermeasures BARDA Portal BARDA…
March 16, 2020
Center for AIDS Research Resource Support
Informational Webinar: March 25, 2020 (link) Required Core Consultation Deadline: April 15, 2020 Application Deadline: April 22, 2020 Purpose: To encourage investigators, especially those junior or new to CFAR, to leverage existing CFAR services, data, and/or specimens for short-term, innovative HIV-related pilot projects that are likely to generate sufficient data for subsequent applications for future research funding. Eligibility: A Principal Investigator must:…
March 12, 2020
UW Innovation Highlighted on Italian TV for Treating Covid-19
Dr. Simone Perazzolo, a scientist in the TLC-ART Program, was featured on Italian national TV explaining how an FDA approved protease inhibitor called Lopinavir (Kaletra) may be effective against Covid-19 since requires protease enzymes to replicate. He has highlighted targeted and long-acting drug combinations containing Lopinavir + Tenofovir (HIV and Hepatitis B drugs) currently in…
March 6, 2020
Unitaid to Fund $2MM for Oxygen Therapy Innovations
Unitaid, a partner of the UW TLC-ART Program and a funding arm of the WHO, has announced for innovations in the development of fit-for-purpose oxygen therapy for global health and access. Depending on the scope of the project, the funding range is between USD 500k-2M. The deadline is March 19th, 2020. Please follow the link…
January 31, 2020
WE-REACH is Open for Business
The Center for WE-REACH officially launched on Friday January 31st, 2020. With this announcement to ITHS partners in the WWAMI region, the center plans to educate the next generation of life science entrepreneurs and support value-added project funding to accelerate biomedical products from innovation to reach market and impact the community at large. The news…
December 18, 2019
National REACH Conference
On December 9th and 10th, 4 members of the WE-REACH Executive Leadership attended the National REACH conference held at NIH Headquarters in Bethesda, Maryland. Dr. Rodney Ho (WE-REACH PI and Executive Director), Tong Sun (ITHS Executive Director), Jeanette Ennis (CoMotion Associate Director of Innovation Investments), and Dr. Terri Butler (WE-REACH Associate Director of Outreach and…